Cargando…
Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?
A small study in patients with severe sepsis suggested that insulin infused to normalize blood glucose levels increased forearm flow. This clinical observation supports the effect of insulin on the endothelium, as previously shown by in vitro studies and by in vivo animal models of critical illness,...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875501/ https://www.ncbi.nlm.nih.gov/pubmed/20236504 http://dx.doi.org/10.1186/cc8228 |
_version_ | 1782181586757746688 |
---|---|
author | Berghe, Greet Van den |
author_facet | Berghe, Greet Van den |
author_sort | Berghe, Greet Van den |
collection | PubMed |
description | A small study in patients with severe sepsis suggested that insulin infused to normalize blood glucose levels increased forearm flow. This clinical observation supports the effect of insulin on the endothelium, as previously shown by in vitro studies and by in vivo animal models of critical illness, but the clinical consequences remain unclear. |
format | Text |
id | pubmed-2875501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28755012011-02-16 Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? Berghe, Greet Van den Crit Care Commentary A small study in patients with severe sepsis suggested that insulin infused to normalize blood glucose levels increased forearm flow. This clinical observation supports the effect of insulin on the endothelium, as previously shown by in vitro studies and by in vivo animal models of critical illness, but the clinical consequences remain unclear. BioMed Central 2010 2010-02-16 /pmc/articles/PMC2875501/ /pubmed/20236504 http://dx.doi.org/10.1186/cc8228 Text en Copyright ©2010 BioMed Central Ltd |
spellingShingle | Commentary Berghe, Greet Van den Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? |
title | Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? |
title_full | Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? |
title_fullStr | Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? |
title_full_unstemmed | Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? |
title_short | Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? |
title_sort | increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875501/ https://www.ncbi.nlm.nih.gov/pubmed/20236504 http://dx.doi.org/10.1186/cc8228 |
work_keys_str_mv | AT berghegreetvanden increasedbloodflowbyinsulininfusiontargetingnormoglycemiainpatientswithseveresepsisfriendorfoe |